Data / Form D filings / Corvia Medical, Inc.
Corvia Medical, Inc.: Form D filings
Corvia Medical, Inc., a biotechnology company in Tewksbury, MA, filed 5 Form D notices with the SEC between 2013 and 2025. The latest, on June 25, 2025, reports $8.9 million sold of a $11.1 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1 Highwood Drive, Suite 300, Tewksbury, MA, 01876
- Phone
- (978) 654-6123
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1464449
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 25, 2025 | New notice | $11,087,670 | $8,860,552 | $2,227,118 | 10 | Jun 12, 2025 | sec.gov |
| Jan 25, 2021 | New notice | $13,115,114 | $6,265,647 | $6,849,467 | 25 | Jan 15, 2021 | sec.gov |
| Sep 22, 2015 | Amendment | $34,000,001 | $34,000,001 | 9 | Jun 16, 2014 | sec.gov | |
| Jul 1, 2014 | New notice | $34,000,001 | $17,050,000 | $16,950,001 | 9 | Jun 16, 2014 | sec.gov |
| Mar 15, 2013 | New notice | $10,736,836 | $10,736,836 | 10 | Mar 1, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Paul J. LaViolette | Director | |
| Kevin J. Gillis | Director | |
| Gerald J. Brunk | Director | |
| George J. Fazio | Executive Officer, Director | |
| Dan B. Curtis | Executive Officer | |
| David J. Celermajer | Director | |
| Irit J. Yaniv | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jun 23, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Corvia Medical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.